Communicated by Philip D Chilibeck.
Monika Górecka and Krzysztof Krzemiński contributed equally to this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Angiopoietin-like protein 4 (ANGPTL4) regulates lipid metabolism by inhibiting lipoprotein lipase activity and stimulating lipolysis in adipose tissue. The aim of this study was to find out whether the mountain ultra-marathon running influences plasma ANGPTL4 and whether it is related to plasma lipid changes.
Ten healthy men (age 31 ± 1.1 years) completed a 100-km ultra-marathon running. Plasma ANGPTL4, free fatty acids (FFA), triacylglycerols (TG), glycerol (Gly), total cholesterol (TC), low (LDL-C) and high (HDL-C) density lipoprotein-cholesterol were determined before, immediately after the run and after 90 min of recovery.
Plasma ANGPTL4 increased during exercise from 68.0 ± 16.5 to 101.2 ± 18.1 ng/ml (p < 0.001). This was accompanied by significant increases in plasma FFA, Gly, HDL-C and decreases in plasma TG concentrations (p < 0.01). After 90 min of recovery, plasma ANGPTL4 and TG did not differ significantly from the exercise values, while plasma FFA, Gly, TC and HDL-C were significantly lower than immediately after the run.
TC/HDL-C and TG/HDL-C molar ratios were significantly reduced. The exercise-induced changes in plasma ANGPTL4 correlated positively with those of FFA (r = 0.73; p < 0.02), and HDL-C (r = 0.69; p < 0.05). Positive correlation was found also between plasma ANGPTL4 and FFA concentrations after 90 min of recovery (r = 0.77; p < 0.01).
The present data suggest that increase in plasma FFA during mountain ultra-marathon run may be involved in plasma ANGPTL4 release and that increase in ANGPTL4 secretion may be a compensatory mechanism against fatty acid-induced oxidative stress. Increase in plasma HDL-C observed immediately after the run may be due to the protective effect of ANGPTL4 on HDL.
Achten J, Venables MC, Jeukendrup AE (2003) Fat oxidation rates are higher during running compared with cycling over a wide range of intensities. Metabolism 52:747–752 PubMed
Barker KR, Conroy AL, Hawkes M, Murphy H, Pandey P, Kain KC (2016) Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case-control study. J Travel Med 23:1–7
Capostagno B, Bosch A (2010) Higher fat oxidation in running than cycling at the same exercise intensities. Int J Sport Nutr Exerc Metab 20:44–55 PubMed
Catoire M, Mensink M, Boekschoten MV, Hangelbroek R, Müller M, Schrauwen P, Kersten S (2012) Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS O ne 7:e51066. https://doi.org/10.1371/journal.pone.0051066 CrossRef
Catoire M, Alex S, Paraskevopulos N, Mattijssen F, Evers-van Gogh I, Schaart G, Jeppesen J, Kneppers A, Mensink M, Voshol PJ, Olivecrona G, Tan NS, Hesselink MK, Berbée JF, Rensen PC, Kalkhoven E, Schrauwen P, Kersten S (2014) Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise. Proc Natl Acad Sci USA 111:E1043–E1052 PubMed
Chenevière X, Malatesta D, Gojanovic B, Borrani F (2010) Differences in whole-body fat oxidation kinetics between cycling and running. Eur J Appl Physiol 109:1037–1045 PubMed
Dessypris A, Kuoppasalmi K, Adlercreutz H (1975) Plasma cortisol, testosterone, androstenedione and luteinizing hormone (LH) in a non-competitive marathon run. J Steroid Biochem 7:33–37
Dijk W, Kersten S (2014) Regulation of lipoprotein lipase by Angptl4. Trends Endocrinol Metab 25:146–155 PubMed
Drager LF, Yao Q, Hernandez KL, Shin MK, Bevans-Fonti S, Gay J, Sussan TE, Jun JC, Myers AC, Olivecrona G, Schwartz AR, Halberg N, Scherer PE, Semenza GL, Powell DR, Polotsky VY (2013) Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med 188:240–248 PubMedPubMedCentral
Emed LG, Passaglia DG, Guerios ST, João PG, Moser AI, Abdalla DS, Guarita-Souza LC, Mikilita ES, Baena CP, da Costa AB, Faria-Neto JR (2016) Acute modification in plasma lipid levels in ultramarathon runners. J Sports Sci 34:1657–1661 PubMed
Fallon KE, Broad E, Thompson MW, Reull PA (1998) Nutritional and fluid intake in a 100-km ultramarathon. Int J Sport Nutr 8:24–35 PubMed
Georgiadi A, Lichtenstein L, Degenhardt T, Boekschoten MV, van Bilsen M, Desvergne B, Müller M, Kersten S (2010) Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res 106:1712–1721 PubMed
Gill JM, Hardman AE (2003) Exercise and postprandial lipid metabolism: an update on potential mechanisms and interactions with high-carbohydrate diets (review). J Nutr Biochem 14:122–132 PubMed
Gusarova V, O'Dushlaine C, Teslovich TM, Benotti PN, Mirshahi T, Gottesman O, Van Hout CV, Murray MF et al (2018) Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. Nat Commun 9:2252. https://doi.org/10.1038/s41467-018-04611-z CrossRefPubMedPubMedCentral
Hardman AE (1998) The influence of exercise on postprandial triacylglycerol metabolism. Atherosclerosis 141(Suppl 1):S93–S100 PubMed
Helge JW, Rehrer NJ, Pilegaard H, Manning P, Lucas SJ, Gerrard DF, Cotter JD (2007) Increased fat oxidation and regulation of metabolic genes with ultraendurance exercise. Acta Physiol (Oxf) 191:77–86
Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks HF, Hesselink MK, Schrauwen P, Müller M (2009) Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol 29:969–974 PubMed
Kersten S (2014) Physiological regulation of lipoprotein lipase. Biochim Biophys Acta 1841:919–933 PubMed
Keul J, Kohler B, von Glutz G, Lüthi U, Berg A, Howald H (1981) Biochemical changes in a 100 km run: carbohydrates, lipids, and hormones in serum. Eur J Appl Physiol Occup Physiol 47:181–189 PubMed
Kunachowicz H, Nadolna I, Przygoda B, Iwanow K (2017) Food composition tables. PZWL, Warsaw
Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, McCabe EL, Yang E, Shi X, Deo R, Roth FP, Asnani A, Rhee EP, Systrom DM, Semigran MJ, Vasan RS, Carr SA, Wang TJ, Sabatine MS, Clish CB, Gerszten RE (2010) Metabolic signatures of exercise in human plasma. Sci Transl Med 2:33ra37. https://doi.org/10.1126/scitranslmed.3001006 CrossRefPubMedPubMedCentral
Makoveichuk E, Vorrsjö E, Olivecrona T, Olivecrona G (2013) Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface. Biochem Biophys Res Commun 441:941–946 PubMed
Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Müller M, Kersten S (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281:934–944 PubMed
Mrakic-Sposta S, Gussoni M, Moretti S, Pratali L, Giardini G, Tacchini P, Dellanoce C, Tonacci A, Mastorci F, Borghini A, Montorsi M, Vezzoli A (2015) Effects of mountain ultra-marathon running on ROS production and oxidative damage by micro-invasive analytic techniques. PLoS O ne 10:e0141780. https://doi.org/10.1371/journal.pone.0141780 CrossRef
Morio B, Holmbäck U, Gore D, Wolfe RR (2004) Increased VLDL-TAG turnover during and after acute moderate-intensity exercise. Med Sci Sports Exerc 36:801–806 PubMed
Nikkilä EA, Taskinen MR, Rehunen S, Härkönen M (1978) Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism 27:1661–1667 PubMed
Norheim F, Hjorth M, Langleite TM, Lee S, Holen T, Bindesbøll C, Stadheim HK, Gulseth HL, Birkeland KI, Kielland A, Jensen J, Dalen KT, Drevon CA (2014) Regulation of angiopoietin-like protein 4 production during and after exercise. Physiol Rep 2:e12109. https://doi.org/10.14814/phy2.12109 CrossRefPubMedPubMedCentral
O'Brien MJ, Viguie CA, Mazzeo RS, Brooks GA (1993) Carbohydrate dependence during marathon running. Med Sci Sports Exerc 25:1009–1017 PubMed
Rauch HG, Hawley JA, Noakes TD, Dennis SC (1998) Fuel metabolism during ultra-endurance exercise. Pfl Arch 436:211–219
Robciuc MR, Naukkarinen J, Ortega-Alonso A, Tyynismaa H, Raivio T, Rissanen A, Kaprio J, Ehnholm C, Jauhiainen M, Pietiläinen KH (2011) Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins. J Lipid Res 52:1575–1582 PubMedPubMedCentral
Robciuc MR, Skrobuk P, Anisimov A, Olkkonen VM, Alitalo K, Eckel RH, Koistinen HA, Jauhiainen M, Ehnholm C (2012) Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS O ne 7:e46212. https://doi.org/10.1371/journal.pone.0046212 CrossRef
Roupas ND, Mamali I, Maragkos S, Leonidou L, Armeni AK, Markantes GK, Tsekouras A, Sakellaropoulos GC, Markou KB, Georgopoulos NA (2013) The effect of prolonged aerobic exercise on serum adipokine levels during an ultra-marathon endurance race. Hormones (Athens) 12:275–282
Sansoni V, Vernillo G, Perego S, Barbuti A, Merati G, Schena F, La Torre A, Banfi G, Lombardi G (2017) Bone turnover response is linked to both acute and established metabolic changes in ultra-marathon runners. Endocrine 56:196–204 PubMed
Smart-Halajko MC, Robciuc MR, Cooper JA, Jauhiainen M, Kumari M, Kivimaki M, Khaw KT, Boekholdt SM, Wareham NJ, Gaunt TR, Day IN, Braund PS, Nelson CP, Hall AS, Samani NJ, Humphries SE, Ehnholm C, Talmud PJ (2010) The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk. Arterioscler Thromb Vasc Biol 30:2277–2282 PubMedPubMedCentral
Sjödin B, Svedenhag J (1985) Applied physiology of marathon running. Sports Med 2:83–99 PubMed
Sonnenburg WK, Yu D, Lee EC, Xiong W, Gololobov G, Key B, Gay J, Wilganowski N, Hu Y, Zhao S, Schneider M, Ding ZM, Zambrowicz BP, Landes G, Powell DR, Desai U (2009) GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4. J Lipid Res 50:2421–2429 PubMedPubMedCentral
Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F, Stefan N, Fritsche A, Häring HU (2009) Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58:579–589 PubMedPubMedCentral
Stejskal D, Karpísek M, Reutová H, Humenanská V, Petzel M, Kusnierová P, Vareka I, Vareková R, Stejskal P (2008) Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA. Gen Physiol Biophys 27:59–63 PubMed
Sundsfjord JA, Stromme SB, Avaag A (1975) Plasma aldosterone, plasma renin activity and Cortisol during exercise. In: Howald H, Portmans JR (eds) Metabolic adaptation to prolonged physical exercise. Birkhäuser, Basel, pp 308–314
Tjeerdema N, Georgiadi A, Jonker JT, van Glabbeek M, Alizadeh Dehnavi R, Tamsma JT, Smit JW, Kersten S, Rensen PC (2014) Inflammation increases plasma angiopoietin-like protein 4 in patients with the metabolic syndrome and type 2 diabetes. BMJ Open Diabetes Res Care 2:e000034. https://doi.org/10.1136/bmjdrc-2014-000034 CrossRefPubMedPubMedCentral
Tomaszewski M, Charchar FJ, Crawford L, Zukowska-Sczechowska E, Grzeszczak W, Sattar N, Dominiczak AF (2004) Serum C-reactive protein and lipids in ultra-Marathon runners. Am J Cardiol 94:125–126 PubMed
Waśkiewicz Z, Kłapcińska B, Sadowska-Krępa E, Czuba M, Kempa K, Kimsa E, Gerasimuk D (2012) Acute metabolic responses to a 24-h ultra-marathon race in male amateur runners. Eur J Appl Physiol 112:1679–1688 PubMed
Weigert C, Hoene M, Plomgaard P (2019) Hepatokines-a novel group of exercise factors. Pfl Arch 471:383–396
Vaisberg M, Bachi AL, Latrilha C, Dioguardi GS, Bydlowski SP, Maranhão RC (2012) Lipid transfer to HDL is higher in marathon runners than in sedentary subjects, but is acutely inhibited during the run. Lipids 47:679–686 PubMed
Van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol 32:712–713 PubMed
Van Raalte DH, Brands M, Serlie MJ, Mudde K, Stienstra R, Sauerwein HP, Kersten S, Diamant M (2012) Angiopoietin-like protein 4 is differentially regulated by glucocorticoids and insulin in vitro and in vivo in healthy humans. Exp Clin Endocrinol Diabetes 120:598–603 PubMed
Yang LY, Yu CG, Wang XH, Yuan SS, Zhang LJ, Lang JN, Zhao D, Feng YM (2017) Angiopoietin-like protein 4 is a high-density lipoprotein (HDL) component for HDL metabolism and function in nondiabetic participants and type-2 diabetic patients. J Am Heart Assoc 6:e005973. https://doi.org/10.1161/JAHA117.005973 CrossRefPubMedPubMedCentral
- Effect of mountain ultra-marathon running on plasma angiopoietin-like protein 4 and lipid profile in healthy trained men
Andrzej Wojciech Ziemba
- Springer Berlin Heidelberg
European Journal of Applied Physiology
Print ISSN: 1439-6319
Elektronische ISSN: 1439-6327